Third Rock Ventures III L.P. 13D and 13G filings for Nurix Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:04 pm Sale |
2022-12-31 | 13G | Nurix Therapeutics, Inc. NRIX |
Third Rock Ventures III L.P. | 184,544 0.400% |
-2,366,213 (-92.77%) |
Filing |
| 2022-02-14 4:57 pm Sale |
2021-12-31 | 13G | Nurix Therapeutics, Inc. NRIX |
Third Rock Ventures III L.P. | 2,550,757 5.700% |
-2,871,792 (-52.96%) |
Filing |
| 2021-02-16 4:15 pm Purchase |
2020-12-31 | 13G | Nurix Therapeutics, Inc. NRIX |
Third Rock Ventures III L.P. | 5,422,549 14.000% |
5,422,549 (New Position) |
Filing |